TEPEZZA

This brand name is authorized in United States.

Active ingredients

The drug TEPEZZA contains one active pharmaceutical ingredient (API):

`1`	Teprotumumab UNII `Y64GQ0KC0A` - TEPROTUMUMAB
	Teprotumumab’s mechanism of action in patients with Thyroid Eye Disease has not been fully characterized. Teprotumumab binds to IGF-1R and blocks its activation and signaling.
	Read more about Teprotumumab

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TEPEZZA Powder for solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	75987-130

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.